Efficacy Study of TLN-232 in Patients With Recurring Metastatic Melanoma
Clinical trial NCT00735332 · TERMINATED
Trial details
- NCT number
- NCT00735332
- Sponsor
- Thallion Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-08-01
- Primary completion
- 2009-12-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.